longbridgelongbridge
  • 平台特色
    特色
    投資產品私人財富管理交易工具行情服務分析工具資訊服務開發者平台
    賬戶類型
    個人客戶機構客戶
  • Café
longbridge
© 2026 Longbridge|服務條款隱私政策

Decoy Therapeutics

DCOY

----
開始交易
概覽概覽新聞新聞討論討論財務財務預測預測估值估值股東股東簡況簡況
LongbridgeAI
全部股東機構持有者內部人士

全部股東

股東類型

  • 公眾及其他88.70%
  • 個人與內幕人士10.50%
  • 機構投資者0.80%

主要股東

主要股東 最新
股東
Frederick PierceCEO & Director
5.32%3.48 萬5.06%+3.35 萬31/08/2026
Mark RosenblumExecutive VP of Finance & CFO
1.73%1.14 萬1.42%+9,682.0031/08/2026
Barbara HibnerChief Scientific Officer
0.64%4,216.000.64%+4,216.0031/08/2026
Vanguard Capital Management, LLC
0.62%4,034.00--+4,034.0030/06/2026
Peter MarschelChief Business Officer
0.60%3,900.000.60%+3,900.0031/08/2026
Arnold HanishIndependent Director
0.52%3,418.000.52%+3,416.0031/08/2026
William McVicarIndependent Chairman of the Board
0.46%3,002.000.46%+3,000.0031/08/2026
Teresa BurlesonIndependent Director
0.31%2,002.000.31%+2,000.0031/08/2026
Jonathan LieberIndependent Director
0.31%2,002.000.31%+2,000.0031/08/2026
Paul LammersIndependent Director
0.31%2,001.000.31%+2,000.0031/08/2026
Patricia GauthierDirector
0.31%2,000.00--+2,000.0031/08/2026
Geode Capital Management, LLC
0.14%910.000.03%+031/12/2025
Tower Research Capital Europe Limited
0.04%256.000.15%-765.0030/06/2026
David ArthurFormer Director
<0.01%34.00<0.01%+030/04/2026
UBS Asset Management AG
<0.01%25.000.10%-521.0030/06/2026
Caitong International Asset Management Co., Limited
<0.01%2.00--+2.0030/06/2026
Bruce McCreedyFormer Interim Chief Scientific Officer & Independent Director
<0.01%1.00<0.01%+024/10/2025
Advisory Services Network, LLC
0.00%0.00<0.01%-41.0030/06/2026
Morgan Stanley
0.00%0.00<0.01%-1.0030/06/2026
Armistice Capital LLC
0.00%0.000.08%-421.0009/06/2026